Cover Image
市場調查報告書

葡萄膜炎:全球臨床實驗趨勢

Uveitis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 237449
出版日期 內容資訊 英文 164 Pages
訂單完成後即時交付
價格
Back to Top
葡萄膜炎:全球臨床實驗趨勢 Uveitis Global Clinical Trials Review, H2, 2016
出版日期: 2016年11月30日 內容資訊: 英文 164 Pages
簡介

本報告提供葡萄膜炎的治療藥相關臨床實驗調查分析,彙整臨床實驗數和受驗人數,各階段及各方面狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等資料。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:葡萄膜炎臨床實驗數量佔眼科系疾病臨床實驗數量比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:葡萄膜炎臨床實驗數量佔眼科系疾病臨床實驗數量比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 葡萄膜炎治療藥

有潛力的藥劑

  • 最新臨床實驗新聞:葡萄膜炎

臨床實驗簡介的基本資料

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3973CTIDB

GlobalData's clinical trial report, "Uveitis Global Clinical Trials Review, H2, 2016" provides an overview of Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Five Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Uveitis to Ophthalmology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Uveitis to Ophthalmology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Uveitis Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Latest Clinical Trials News on Uveitis 30
  • Nov 28, 2016: Santen Announces Phase III SAKURA Program Topline Results in Patients with Non-Infectious Uveitis of the Posterior Segment 30
  • Sep 27, 2016: Idera Pharmaceuticals Presents New Third Generation Antisense (3GA) Data at the 12th Annual Meeting of the Oligonucleotide Therapeutics Society 30
  • Clinical Trial Profile Snapshots 32

Appendix 161

  • Abbreviations 161
  • Definitions 161
  • Research Methodology 162
  • Secondary Research 162
  • About GlobalData 163
  • Contact Us 163
  • Disclaimer 163
  • Source 164

List of Tables

List of Tables

  • Uveitis Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Uveitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
  • Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
  • Proportion of Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Uveitis Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

List of Figures

  • Uveitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Uveitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
  • Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
  • Proportion of Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Uveitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 162
Back to Top